Diabetic nephropathy and extracellular matrix - Wikidata - awgldk - TriplyDB

Diabetic nephropathy and extracellular matrix

Diabetic nephropathy and extracellular matrix

http://www.wikidata.org/entity/Q26996008

about

Matrix Metalloproteinases in Non-Neoplastic Disorders.Histone Acetylation and Its Modifiers in the Pathogenesis of Diabetic Nephropathy MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy Macrophage TGF-β1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic Conditions Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator.Glucose or Altered Ceramide Biosynthesis Mediate Oxygen Deprivation Sensitivity Through Novel Pathways Revealed by Transcriptome Analysis in Caenorhabditis elegans.Heparan sulfate biosynthesis: methods for investigation of the heparanosome Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.The proteasome inhibitor, MG132, attenuates diabetic nephropathy by inhibiting SnoN degradation in vivo and in vitro.Effects of high glucose on integrin activity and fibronectin matrix assembly by mesangial cells A glimpse of matrix metalloproteinases in diabetic nephropathy.Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation The anti-inflammatory and antifibrotic effects of Coreopsis tinctoria Nutt on high-glucose-fat diet and streptozotocin-induced diabetic renal damage in rats.Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-β1/Smad Signaling Pathway.The effect of acute and long-term physical activity on extracellular matrix and serglycin in human skeletal muscle The Inhibitory Effect of Rhein on Proliferation of High Glucose-induced Mesangial Cell Through Cell Cycle Regulation and Induction of Cell Apoptosis.miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy An introduction to proteoglycans and their localization Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway.Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.Effects of astragalosides from Radix Astragali on high glucose-induced proliferation and extracellular matrix accumulation in glomerular mesangial cells.Flow patterns regulate hyperglycemia-induced subendothelial matrix remodeling during early atherogenesis.Histone lysine methylation in diabetic nephropathy.Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy.KATP channels in high glucose-induced rat mesangial cell proliferation and release of MMP-2 and fibronectin High Glucose-Induced Hypomethylation Promotes Binding of Sp-1 to Myo-Inositol Oxygenase: Implication in the Pathobiology of Diabetic Tubulopathy.Lentiviral Vector-Mediated FoxO1 Overexpression Inhibits Extracellular Matrix Protein Secretion Under High Glucose Conditions in Mesangial Cells.Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria.Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.Role and impact of the extracellular matrix on integrin-mediated pancreatic β-cell functions.Reduced sulfation of chondroitin sulfate but not heparan sulfate in kidneys of diabetic db/db mice.Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.Matrix Metalloproteinase-9 -1562C/T Gene Polymorphism Is Associated with Diabetic Nephropathy.N-glycosylation proteome enrichment analysis in kidney reveals differences between diabetic mouse models.Overexpression of the FoxO1 Ameliorates Mesangial Cell Dysfunction in Male Diabetic Rats.Potassium channels, renal fibrosis, and diabetes.

P2860

Q26741827-9A1650A2-C7F9-4C29-930F-74FF4B923687 Q26744442-E5185606-967E-4CF7-AF7C-D5BF54B2F79F Q26766102-6256AA9B-85EC-4018-90A7-E2FA1FB5ED2D Q28817901-AC908294-547E-4B34-892D-07E638719120 Q30353876-9A9CD258-C3F5-44B9-8301-0A9D64430FAF Q30384879-1CA58620-801A-46EE-BD7C-4CA14DF2DEF6 Q30823934-09B94F13-5944-4716-B8CC-BFDF27A5043C Q31085481-B77002F0-7C9C-4A40-ADD5-753BAA4D7106 Q31154570-362B05B8-356A-48BF-89E6-6FCBD39C4B66 Q33805132-8FBE7E83-66EF-4D62-85A8-05DD0D861E0A Q34081401-DD46AFC7-ADDC-4318-88B0-050A990F49DC Q34796034-02B44A1B-7186-4C79-9DED-84BAB8D0C1C0 Q35073484-4E62CADB-FEA6-4275-965C-CE6997E919C8 Q35766321-357253B6-349E-4A7E-AA21-FB48A9E4C926 Q35968598-FAED527C-7C91-4BCD-920F-AD3F422CD5CA Q36036383-989F0217-C052-42C4-8D7D-03624A10B06C Q36046074-8E8D362B-5BB7-48CF-8723-07FA5D908257 Q36310864-1F215190-F322-45F3-BBF3-1BEB3EE6C670 Q36325650-574375A3-4C55-4EC1-BAA0-76B2E3FC8A0A Q36481630-C57CDC84-8D41-4767-8992-474EE99344F6 Q36579281-4FBE2DFD-BEBC-4253-A5E4-E22E00046F07 Q36891626-745669CB-6ED6-4B9B-AEBB-977B4D5F7608 Q36954059-EBAC2B36-C810-493F-83D6-807AE9B3FF59 Q37526511-9417376E-22D6-4D83-A978-F771D29333E6 Q38248614-9F671798-A649-42C8-9BC7-8103812AEEF4 Q38332511-93E54D49-0497-4382-B82A-57E58411A643 Q38661556-A03687ED-1E20-4DF0-B65E-7F4E07E4959C Q38663562-9DA2D139-B8CA-4244-9634-6057B35C2DB5 Q38695983-002F3EBE-0D93-45DF-A9F4-226E3EC3D5A5 Q38716178-78CF6AFD-EB18-4F18-8EAB-D08799435102 Q38866424-68CDCF5C-4842-422C-897E-6832CC572378 Q38903408-7E629952-CF14-4013-B54A-9610E5037332 Q38982294-7D6E8756-BC05-40D5-98DF-BFB33CB78486 Q39165118-B5AB0F72-9032-4A97-BC2F-2116A61A6A48 Q39404017-0678CF77-8417-4E18-BAF3-C22392A7E1C0 Q39427404-C5590761-55D3-44D1-A4E7-B647D820B72D Q40580698-3E815242-B522-4A18-B3E3-184CB8F6B8C1 Q41470895-65FEDA83-A6AB-4E1C-8E86-75E7635C78A6 Q41704237-49E7A1C5-0537-4F44-88B2-9FDDDE243C93 Q43083167-3280D4D9-1A16-407C-A1E5-97AF2C3CDCB3

P2860

Diabetic nephropathy and extracellular matrix

http://www.wikidata.org/entity/Q26996008

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Diabetic nephropathy and extracellular matrix

@ast

Diabetic nephropathy and extracellular matrix

@en

Diabetic nephropathy and extracellular matrix

@nl

type

label

Diabetic nephropathy and extracellular matrix

@ast

Diabetic nephropathy and extracellular matrix

@en

Diabetic nephropathy and extracellular matrix

@nl

prefLabel

Diabetic nephropathy and extracellular matrix

@ast

Diabetic nephropathy and extracellular matrix

@en

Diabetic nephropathy and extracellular matrix

@nl

P1433

Q26996008-6A5FC7DD-1F9E-48C0-90B2-0CDB88AF642A

P1476

Q26996008-7DA68368-593F-49EF-8FEE-1D4F60542FB9

P2093

Q26996008-07099671-8FB2-4F42-9AD6-0A215ED6937F

Q26996008-6DFE94ED-6E0D-4B7B-A544-AA07E3765E4E

Q26996008-7C0EEC79-80E7-4D28-8C2A-2F8E829F83DD

P2860

Q26996008-009BEC6F-2DD3-4CE7-83E8-081E7C8BDBAA

Q26996008-04785900-C199-4F67-AE95-5F6B0A43BAF2

Q26996008-11B1FEB4-CC4D-4079-8720-8F872D855B01

Q26996008-1A74BDD8-CD87-4DC8-BAB6-591CE3CAF9BC

Q26996008-1FBA6A98-7232-473E-96E7-42DB6DC4107D

Q26996008-247E3631-EF5D-4C19-9F1E-1EE49D52AA5A

Q26996008-24FF694A-2C1B-4FC8-9CBD-2819820AEB4C

Q26996008-26BE6227-00B4-447B-8D5F-85890CF6CF43

Q26996008-26E0C17E-B0F4-48F8-A083-3202ADC915D7

Q26996008-34232E24-06D7-46A3-9DE4-5318358CF348

P304

Q26996008-B6BB82A2-3895-4E43-BB37-C583FE787D3B

P31

Q26996008-13FAE99A-EEAE-4019-BC62-EFC233D66715

P3181

Q26996008-09A65358-C3FE-4119-8C13-2B4F3F044E0F

P356

Q26996008-331D9FEB-2513-47FF-A92E-AC231BF11113

P407

Q26996008-6A2969B2-C0A3-497F-8D95-9454F1F6E708

P433

Q26996008-004D508E-117A-4864-9145-851C83F05581

P478

Q26996008-2CC902B5-F42C-4BA6-9DE3-D7C7614960A3

P577

Q26996008-42E90DD2-C6EE-4399-BEC9-D4FD86DC582B

P698

Q26996008-6484140D-3666-43CF-98D8-6A1DD27D5150

P921

Q26996008-05DA74E0-F352-4DC1-89F5-6972AE5154BC

P932

Q26996008-62334FA5-D029-4BD6-BE99-18E97858D150

P3181

P356

0022155412465073

P1433

Journal of Histochemistry & Cytochemistry

P1476

Diabetic nephropathy and extracellular matrix

@en

P2093

F. P. Reinholt

http://www.w3.org/2001/XMLSchema#string

S. O. Kolset

http://www.w3.org/2001/XMLSchema#string

T. Jenssen

http://www.w3.org/2001/XMLSchema#string

P2860

Matrix metalloproteinases in kidney homeostasis and diseases

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications

WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier

Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney

Global estimates of the prevalence of diabetes for 2010 and 2030

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

The pathobiology of diabetic complications: a unifying mechanism

P304

976-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

922265

http://www.w3.org/2001/XMLSchema#string

P356

10.1369/0022155412465073

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23103723

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

P932

3527883

http://www.w3.org/2001/XMLSchema#string